FDA Finalizes Guidance on Biowaivers and Biopharmaceutical Classification

Drug Industry Daily
A A
The FDA finalized its May 2015 guidance on how makers of immediate-release, solid, oral products can request waivers for subsequent in vivo bioavailability and bioequivalence studies.

To View This Article:

Login

Subscribe To Drug Industry Daily